Insider Selling: ConvaTec Group PLC (LON:CTEC) Insider Sells 436,692 Shares of Stock

ConvaTec Group PLC (LON:CTECGet Free Report) insider Karim Bitar sold 436,692 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of GBX 256 ($3.32), for a total transaction of £1,117,931.52 ($1,449,600.00).

Karim Bitar also recently made the following trade(s):

  • On Friday, March 14th, Karim Bitar sold 132,253 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 256 ($3.32), for a total transaction of £338,567.68 ($439,014.11).

ConvaTec Group Stock Up 0.4 %

Shares of ConvaTec Group stock opened at GBX 258.17 ($3.35) on Friday. The company has a debt-to-equity ratio of 85.32, a current ratio of 2.26 and a quick ratio of 0.96. The company has a 50-day moving average of GBX 247.69 and a 200 day moving average of GBX 234.80. The firm has a market cap of £6.57 billion, a price-to-earnings ratio of 43.48, a PEG ratio of 0.93 and a beta of 0.64. ConvaTec Group PLC has a 1 year low of GBX 211.80 ($2.75) and a 1 year high of GBX 295.20 ($3.83).

ConvaTec Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, April 17th will be paid a $0.05 dividend. This represents a dividend yield of 1.36%. This is a positive change from ConvaTec Group’s previous dividend of $0.02. The ex-dividend date is Thursday, April 17th. ConvaTec Group’s dividend payout ratio (DPR) is presently 84.20%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 310 ($4.02) target price on shares of ConvaTec Group in a research report on Wednesday, March 5th.

Get Our Latest Stock Report on CTEC

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Featured Articles

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.